Evidence map›Paper›PMID 33377645›Full record

ArticleClinical and translational medicine2020

Increased risk of brain metastases among patients with melanoma and PROM2 expression in metastatic lymph nodes.

Thuy Thi Nguyen, Guillaume Gapihan, Pauline Tetu, Frédéric Pamoukdjian, Morad El Bouchtaoui, Christophe Lebœuf, Jean-Paul Feugeas, Justine Paris, Barouyr Baroudjian, Julie Delyon and 5 more

Open access · goldAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and translational medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 2 countries.

Thuy Thi NguyenINSERM U942, Universités de Paris et Sorbonne Paris Nord, Bobigny, France.
Guillaume GapihanINSERM U942, Universités de Paris et Sorbonne Paris Nord, Bobigny, France.
Pauline TetuDermatologie, AP-HP Hôpital Saint Louis, Paris, France.
Frédéric PamoukdjianINSERM U942, Universités de Paris et Sorbonne Paris Nord, Bobigny, France.
Morad El BouchtaouiINSERM U942, Universités de Paris et Sorbonne Paris Nord, Bobigny, France.
Christophe LebœufINSERM U942, Universités de Paris et Sorbonne Paris Nord, Bobigny, France.
Jean-Paul FeugeasINSERM U722, Paris, France.
Justine ParisINSERM U942, Universités de Paris et Sorbonne Paris Nord, Bobigny, France.
Barouyr BaroudjianDermatologie, AP-HP Hôpital Saint Louis, Paris, France.
Julie DelyonDermatologie, AP-HP Hôpital Saint Louis, Paris, France.
Samia MourahHôpital Saint-Louis, Université de Paris, Paris, France.
Céleste LebbéHôpital Saint-Louis, Université de Paris, Paris, France.
Anne JaninINSERM U942, Universités de Paris et Sorbonne Paris Nord, Bobigny, France.
Guilhem BousquetINSERM U942, Universités de Paris et Sorbonne Paris Nord, Bobigny, France.ORCID https://orcid.org/0000-0001-5594-6694
Maxime BattistellaHôpital Saint-Louis, Université de Paris, Paris, France.
Inserm · FRHôpital Saint-Louis · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33377645
PMCPMC7711084
OpenAlexW3107398536

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.